Do you or someone you know have a small, newly diagnosed choroidal Melanoma?

Aura Biosciences is currently enrolling patients in the global Phase 3 CoMpass trial to evaluate the safety and efficacy of bel-sar for the first-line treatment of adult patients with small choroidal melanoma or indeterminate lesions.

See link below for more information on screening and enrolling sites for primary treatment of small choroidal melanoma. If someone you know needs a small eye lesion treated, share to help them have a vision preserving option.